RxDoctor Payments Data

Parkpoom Phatharacharukul, MD

Gastroenterology · St Louis Park, MNNPI 1205254547

Payments from drug & device makers

$899in general payments, 2019–2025

Across 30 payments — averaging $29.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$296
  • Johnson & Johnson$234
  • Gilead$100
  • Sanofi$87
  • Endogastric Solutions, Inc$57
  • Nestle Healthcare Nutrition Inc.$31
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$70879%
  • Education$19121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$899 in reported general payments places this provider in the 60th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota

Medicare billing

Part B allowed, 2024
$59,517
Medicare patients
214
Services billed
746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$153,067
LinzessLinaclotide17$11,617
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl256$4,921
Omeprazole154$1,906
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl51$1,011
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl40$790
Pantoprazole Sodium26$639
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg28$530
Ondansetron Hcl317$482

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$296$11,61717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 365 gastroenterology providers in Minnesota.

Other gastroenterology in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →